What Aegis Sciences does

Aegis Sciences Corporation is a privately held forensic toxicology and clinical laboratory founded in 1990 and headquartered in Nashville, Tennessee. The company performs definitive drug and substance testing on urine, oral fluid, and blood specimens using liquid chromatography-tandem mass spectrometry (LC-MS/MS) under CLIA and College of American Pathologists (CAP) standards, and serves a diverse set of customers including pain management providers, behavioral health and substance use disorder treatment providers, professional and amateur sports organizations, pharmaceutical companies, and public health agencies.

The company's product portfolio is organized around branded clinical offerings: PainComp and AcuRise ID for adherence monitoring; a continuously updated Novel Psychoactive Substances (NPS) testing menu aligned with CFSRE/SOFT recommendations; the NPS Insights Dashboard providing real-time national surveillance visualization; InterACT Rx for drug-drug interaction detection (co-developed with QURE); BioDetect; Kratom Alkaloids and expanded Cannabinoid testing; Clinical Blood Testing; Infectious Disease Testing; and the Zero-Tolerance anti-doping service operated out of the Wilma Rudolph Sports Testing Laboratory, where Aegis is the largest independent anti-doping laboratory in the U.S. serving more than 150 colleges, universities, high schools, and professional sports organizations. CareEvolve is the client-provider portal for test ordering and results delivery.

Aegis generates revenue on a per-test basis, billed primarily through Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation, with the UnitedHealthcare Preferred Lab Network relationship expanding in-network access. Go-to-market is sales-led, directed at healthcare providers who order testing through the Aegis platform, supplemented by clinical education content, webinars, the NPS Insights Dashboard, and conference participation. In June 2025 the company completed a $170 million debt refinancing to support continued investment in laboratory infrastructure and service expansion.

Name

Aegis Sciences

Legal name

Aegis Sciences Corporation

Website

http://www.aegislabs.com/

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Aegis Sciences Corporation is a Nashville-based forensic toxicology and clinical laboratory that performs definitive LC-MS/MS drug and substance testing on urine, oral fluid, and blood for healthcare providers, sports organizations, biopharma companies, and public health agencies across the United States.

Ownership category

akta.pro rank

Product category

Forensic Toxicology and Clinical Drug Testing Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF)

akta.pro secondary industries

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)

Keywords

• Forensic toxicology laboratory
• Clinical drug testing
• Medication adherence monitoring
• Novel psychoactive substances
• Anti-doping testing services

Headquarters

HQ city

Nashville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Drug Testing Services: Healthcare providers order definitive drug testing (urine, oral fluid, or blood) for their patients. Aegis bills per test, typically covered by Medicare, Managed Medicaid, Commercial Insurance, and Workers' Compensation. Testing spans adherence monitoring, NPS detection, clinical blood testing, and infectious disease testing.
2. Sports Anti-Doping Testing: Aegis provides Zero-Tolerance® drug testing services to professional sports organizations, colleges, universities, high schools, and amateur sports bodies. Revenue is generated per test or through contracted testing agreements.
3. Biopharma / Molecular Diagnostic Services: Aegis provides clinical trial services, pharmacogenetic testing, and other molecular diagnostic services to pharmaceutical companies, generating revenue through per-test fees or contracted service agreements.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Aegis Sciences Corporation operates a CLIA- and CAP-accredited forensic toxicology and healthcare laboratory that delivers definitive drug testing on urine, oral fluid, and blood specimens using LC-MS/MS technology. The company sells adherence monitoring panels (PainComp®, AcuRise ID™), novel psychoactive substances (NPS) testing, drug-drug interaction decision support (InterACT Rx), Zero-Tolerance® anti-doping testing, BioDetect, clinical blood testing, infectious disease testing, and biopharma/molecular diagnostic services to healthcare providers, sports organizations, public health agencies, and pharmaceutical clients through its CareEvolve ordering platform.

Product overview

Aegis Sciences Corporation is a forensic toxicology and healthcare laboratory founded in 1990, providing science-driven drug testing and consulting services. The company offers a unified platform of clinical laboratory testing services with multiple branded products and modules. Core offerings include PainComp and AcuRise ID for adherence monitoring across pain management, mental illness, and substance use disorder; Novel Psychoactive Substances (NPS) testing with the proprietary NPS Insights Dashboard for real-time tracking; Kratom Alkaloids and Cannabinoids testing for emerging substances; InterACT Rx for drug-drug interaction management; BioDetect for bio-detection; Clinical Blood Testing; Sports Testing under the Zero-Tolerance brand; and Infectious Disease Testing. Additional services include Oral Fluid Testing and Biopharma Lab Services. CareEvolve serves as the client-provider ordering and practice management platform. Testing is performed using definitive LC-MS/MS methods on urine, oral fluid, or blood specimens.

Differentiator

Problem solved

Functional benefit

Brands

• PainComp: Pain management adherence testing designed to assure complete care for individuals receiving treatment for chronic pain, testing for adherence with prescribed medications.
• AcuRise ID
• Zero-Tolerance
• InterACT Rx
• NPS Insights Dashboard
• BioDetect
• Wilma Rudolph Sports Testing Laboratory

Products and services

• Aegis PainComp Adherence testing designed for individuals receiving treatment for chronic pain, providing definitive verification that patients are only taking prescribed medications and are not using non-prescribed or illicit drugs. Sold to pain management clinicians and practice groups as a standalone adherence monitoring service.
• Aegis AcuRise ID Adherence testing for clinicians treating mental illness and substance use disorder, providing objective measurement of medication adherence and assessment of non-prescription substances that may impact psychiatric symptoms or recovery. Sold to behavioral health, addiction medicine, and SUD treatment providers as a standalone adherence monitoring service.
• Novel Psychoactive Substances (NPS) Testing

Quantifiable outcome

• Physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by drug-drug interactions, resulting in improved patient outcomes.

Named customers7 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• QUREcoreStrategic or Co-development PartnerAegis and QURE collaborated on InterACT Rx, a drug-drug interaction detection tool. Results showed physicians using InterACT Rx were 3x more likely to recognize and treat patients impacted by DDIs, resulting in improved patient outcomes. This partnership represents joint product development to enhance clinical decision support.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Quest Diagnostics: Quest Diagnostics is the largest U.S. clinical reference laboratory, providing routine and specialty diagnostic testing including pain management and substance abuse toxicology panels. It competes directly with Aegis for healthcare provider drug testing volumes and payer network inclusion.
• Eurofins Scientific: Eurofins is a global laboratory services group providing clinical diagnostics, pharmaceutical testing, and forensic toxicology services. It competes with Aegis in clinical trial and biopharma lab services, and operates specialized toxicology and drug testing offerings comparable in scope.
• Sonic Healthcare: Sonic Healthcare is an international clinical pathology and diagnostic services provider with U.S. operations including clinical toxicology and drug monitoring. It competes with Aegis for healthcare provider testing volume and has the scale advantages of a multi-region operator.
• Laboratory Corporation of America (LabCorp): LabCorp is one of the two largest U.S. clinical reference laboratory networks, offering a broad menu of routine and esoteric clinical lab testing including toxicology and drug monitoring. It competes with Aegis on payer contracts and provider-direct drug testing but operates at far greater scale and breadth.

Direct peers

• DrugScan: DrugScan (now part of IT&M) is a specialty clinical toxicology laboratory offering definitive drug and alcohol testing for pain management, addiction treatment, and occupational health — overlapping directly with Aegis's clinical drug testing business and customer segments.
• Psychemedics Corporation: Psychemedics is a specialty laboratory offering hair-based drug testing for workplace, legal, and sports applications. While Aegis uses LC-MS/MS on urine/oral fluid and Psychemedics uses hair, both compete for anti-doping and drug testing contracts in similar customer verticals.
• Millennium Health: Millennium Health is a specialty clinical laboratory focused on definitive drug testing, particularly urine drug monitoring for pain management, behavioral health, and substance use disorder — directly overlapping Aegis's PainComp and AcuRise ID target segments and provider base.
• USDTL (United States Drug Testing Laboratories): USDTL is a specialty forensic and clinical toxicology laboratory providing definitive drug testing using LC-MS/MS for substance use disorder, pain management, prenatal, and workplace testing — directly comparable in technology, methodology, and customer base to Aegis.
• Cordant Health Solutions: Cordant Health Solutions provides medication monitoring, toxicology screening, and behavioral health laboratory services for healthcare providers and criminal justice customers. It overlaps directly with Aegis in clinical drug testing, adherence monitoring, and substance use disorder segments.

Emerging players

• Myriad Genetics: Myriad Genetics provides molecular diagnostic testing including pharmacogenomics that intersects with Aegis's biopharma and pharmacogenetic testing offering. While focused on hereditary cancer and women's health, its molecular diagnostics platform overlaps in clinical trial and personalized medicine services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/aegis-sciences-corporation

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aegis Sciences